Prognostic role of stress/rest myocardial perfusion scintigraphy in patients with cardiac syndrome x

详细信息    查看全文

• 作者：Gabriele Fragasso^a ; ^{gabriele.fragasso@hsr.it" class="auth_mail} ; Ludovica Lauretta^a ; Elena Busnardo^b ; Michela Cera^a ; Cosmo Godino^a ; Antonio Colombo^c ; Giliola Calori^a ; Paola Todeschini^b ; Elena Spinapolice^b ; Alberto Cappelletti^a ; Luigi Gianolli^b ; Alberto Margonato^a
• 关键词：Cardiac syndrome X ; Myocardial perfusion scintigraphy ; SPECT ; Normal coronary arteries ; Prognosis
• 刊名：International Journal of Cardiology
• 出版年：15 May 2014
• 年：2014
• 卷：173
• 期：3
• 页码：467-471
• 全文大小：363 K

文摘

The prognostic utility of myocardial perfusion scintigraphy (MPS) in patients with angiographically normal coronary arteries has not been evaluated yet. Our aim was to determine the prognostic role of positive MPS in patients with angina, positive exercise test and smooth coronary arteries (syndrome X).

Methods

A total of 156 patients with angina, positive exercise test, positive MPS and normal coronary arteries and 172 patients with angina and positive exercise test who had negative MPS were selected for study. The primary endpoint was combined all-cause mortality and hospitalizations for cardiac causes. The secondary endpoint was hospitalization for cardiac causes.

Results

Kaplan–Meier analysis showed a greater (p = 0.001) incidence of the primary endpoint in patients with positive MPS, compared to those with negative MPS. Additionally, Kaplan–Meier analysis for cardiovascular hospitalization showed a significant difference (p = 0.003) between the two groups. Cox regression analysis, adjusted for age, sex, BMI and antianginal therapy confirmed a significant risk increase for patients with positive MPS, with a hazard ratio (HR) = 3.20 (CI 95%: 1.14–9.02; p = 0.028). Cox analysis for cardiovascular hospitalization also showed a significant risk increase for patients with positive MPS (HR = 3.19; CI 95%: 1.13–9.00; p = 0.03). Finally, Cox analysis showed that patients with positive MPS tend to have a higher risk to remain symptomatic in the follow-up period (HR = 1.614; CI 95%: 0.999–2.607; p = 0.51).

Conclusions

This study shows that inducible myocardial hypoperfusion at MPS in patients with syndrome X could discriminate patients with a more severe prognosis, especially in terms of further hospitalization and symptomatic burden.